Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Ensituximab
Trade Name
Synonyms NEO-102
Drug Descriptions

Ensituximab (NEO-102) is a monoclonal antibody against a form of Muc5ac expressed in pancreatic and colorectal cancers, which may induce cytotoxic immune response against tumor cells (PMID: 27449137, PMID: 32303539).

DrugClasses
CAS Registry Number 1092658-06-4
NCIT ID C90532

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Ensituximab Ensituximab 0 0


Additional content available in CKB BOOST